BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
Abstract Background While some studies suggest that the BRAF V600E mutation correlates with a high-risk phenotype in papillary thyroid microcarcinoma (PTMC), more evidence is necessary before this mutation can be used to help guide decision making in the management of small thyroid nodules. This stu...
Guardado en:
Autores principales: | Jennifer A. Silver, Mariya Bogatchenko, Marc Pusztaszeri, Véronique-Isabelle Forest, Michael P. Hier, Ji Wei Yang, Michael Tamilia, Richard J. Payne |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/69f36f0391804101aeee2d7d2f4dce8f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Del macro al microcarcinoma tiroideo: cambios en las características de presentación del cáncer de tiroides en un centro universitario chileno en 20 años
por: Mosso,Lorena, et al.
Publicado: (2013) -
Clinicopathological Significance of BRAF (V600E), NRAS (Q61K) and TERT (C228T, C250T and SNP Rs2853669) Mutations in Bulgarian Papillary Thyroid Carcinoma Patients
por: Vidinov K., et al.
Publicado: (2021) -
Comparison Between Clinicopathological Characteristics, BRAF V600E and TERT Promoter Mutation of Familial Non-Medullary Thyroid Carcinomas, and Sporadic Case
por: Tian Yang, et al.
Publicado: (2021) -
A cohort study of microwave ablation and surgery for low-risk papillary thyroid microcarcinoma
por: Yuan Zu, et al.
Publicado: (2021) -
Preliminary Study on the Relationship of BRAF Mutations with the Outcome of the First 131I Radiotherapy and Malignant Biological Characteristics in Papillary Thyroid Carcinoma
por: Shangguan L, et al.
Publicado: (2021)